News | 3D-Printed Sperm Cells Could Transform Treatment for Male Infertility
In a laboratory at the University of British Columbia (UBC) in Canada, research that appears to be science fiction is gradually moving toward reality. Dr. Ryan Flannigan, an assistant professor of urologic sciences and a male reproductive medicine specialist, and his team are attempting to use 3D-printing technology to create sperm cells. This could offer an unprecedented possibility for men who currently have no prospect of biological parenthood.
“We are challenging established medical practice,” says Dr. Flannigan. “Every day I see patients with nonobstructive azoospermia (NOA), many of whom have no existing treatment options. This compels us to rethink the problem fundamentally and find a breakthrough.”
Male Infertility: An Overlooked Half of the Problem
About 15% of couples of reproductive age worldwide experience difficulty conceiving, and male factors account for more than half of cases. In one of the most severe forms of male infertility, nonobstructive azoospermia (NOA), the testes produce almost no sperm.
Even microdissection testicular sperm extraction (mTESE) succeeds in only about half of cases. “Success depends on finding a very small area capable of producing sperm among billions of cells in the testes,” says Dr. Flannigan. “Some men may truly have no sperm at all, so we need to create technology that can provide these patients with a possibility of biological parenthood.”
3D-Printing Testicular Cells to Build a Sperm Factory in the Laboratory
The research team uses 3D bioprinting to reconstruct the cellular architecture of human testicular tissue. They are printing not only cells but also a complex microenvironment that replicates the seminiferous tubules, where sperm develop.
“Sperm production is not a single-cell process. It is a complex process involving contact and signaling among more than 20 cell types,” Dr. Flannigan explains. “We are not simply growing cells; we are creating an environment.”
The team developed a highly biomimetic 3D-printed model to support human testicular stem cells. By regulating growth factors and nutrients, they are attempting to induce these cells to differentiate into mature sperm.
Research Collaboration Across Disciplines: Turning Science Fiction Into Reality
“This research could not progress without interdisciplinary collaboration,” Dr. Flannigan emphasizes. His team spans computational biology, mathematical modeling, reproductive medicine, materials engineering, and other fields.
UBC researchers Dr. Faraz Hach and Dr. Geoffrey Schiebinger help analyze single-cell sequencing data and identify gene-expression pathways at different stages of differentiation. “We need to understand which signals are required at every stage to guide a stem cell step by step toward becoming sperm.”
The team also works with Dr. Stephanie Willerth of the University of Victoria to develop bio-inks that improve printing precision and cellular compatibility. “A bio-ink must do more than print; it must support cell growth, signaling, and structural development.”
Precision Medicine: Future Infertility Treatment Will Not Be One Size Fits All
Dr. Flannigan says, “Every patient's molecular physiology is unique. Future infertility treatment must therefore be personalized rather than one size fits all.”
The team's research shows that in some patients with azoospermia, the problem lies in dysfunctional support cells rather than the stem cells themselves. “If we can repair those support cells or provide the right signals, we may be able to activate cells that previously could not produce sperm.”
Future treatments may therefore not only regenerate sperm but also be tailored to each patient's condition, putting precision medicine into practice.
Clinical Use Remains Distant, but Progress Offers Hope
The technology is still at an early experimental stage and remains far from use in human treatment. Dr. Flannigan acknowledges that further funding, more complex biosafety studies, and ethical and regulatory review will be needed.
“But we have a clear goal: for this technology eventually to help patients for whom medicine currently has no options.”
Along the way, the team will continue uncovering the molecular mechanisms behind male infertility and opening new avenues for research.
News | 3D-Printed Sperm Cells Could Transform Treatment for Male Infertility
News | 3D-Printed Sperm Cells Could Transform Treatment for Male Infertility
In a laboratory at the University of British Columbia (UBC) in Canada, research that appears to be science fiction is gradually moving toward reality. Dr. Ryan Flannigan, an assistant professor of urologic sciences and a male reproductive medicine specialist, and his team are attempting to use 3D-printing technology to create sperm cells. This could offer an unprecedented possibility for men who currently have no prospect of biological parenthood.
“We are challenging established medical practice,” says Dr. Flannigan. “Every day I see patients with nonobstructive azoospermia (NOA), many of whom have no existing treatment options. This compels us to rethink the problem fundamentally and find a breakthrough.”
Male Infertility: An Overlooked Half of the Problem
About 15% of couples of reproductive age worldwide experience difficulty conceiving, and male factors account for more than half of cases. In one of the most severe forms of male infertility, nonobstructive azoospermia (NOA), the testes produce almost no sperm.
Even microdissection testicular sperm extraction (mTESE) succeeds in only about half of cases. “Success depends on finding a very small area capable of producing sperm among billions of cells in the testes,” says Dr. Flannigan. “Some men may truly have no sperm at all, so we need to create technology that can provide these patients with a possibility of biological parenthood.”
3D-Printing Testicular Cells to Build a Sperm Factory in the Laboratory
The research team uses 3D bioprinting to reconstruct the cellular architecture of human testicular tissue. They are printing not only cells but also a complex microenvironment that replicates the seminiferous tubules, where sperm develop.
“Sperm production is not a single-cell process. It is a complex process involving contact and signaling among more than 20 cell types,” Dr. Flannigan explains. “We are not simply growing cells; we are creating an environment.”
The team developed a highly biomimetic 3D-printed model to support human testicular stem cells. By regulating growth factors and nutrients, they are attempting to induce these cells to differentiate into mature sperm.
Research Collaboration Across Disciplines: Turning Science Fiction Into Reality
“This research could not progress without interdisciplinary collaboration,” Dr. Flannigan emphasizes. His team spans computational biology, mathematical modeling, reproductive medicine, materials engineering, and other fields.
UBC researchers Dr. Faraz Hach and Dr. Geoffrey Schiebinger help analyze single-cell sequencing data and identify gene-expression pathways at different stages of differentiation. “We need to understand which signals are required at every stage to guide a stem cell step by step toward becoming sperm.”
The team also works with Dr. Stephanie Willerth of the University of Victoria to develop bio-inks that improve printing precision and cellular compatibility. “A bio-ink must do more than print; it must support cell growth, signaling, and structural development.”
Precision Medicine: Future Infertility Treatment Will Not Be One Size Fits All
Dr. Flannigan says, “Every patient's molecular physiology is unique. Future infertility treatment must therefore be personalized rather than one size fits all.”
The team's research shows that in some patients with azoospermia, the problem lies in dysfunctional support cells rather than the stem cells themselves. “If we can repair those support cells or provide the right signals, we may be able to activate cells that previously could not produce sperm.”
Future treatments may therefore not only regenerate sperm but also be tailored to each patient's condition, putting precision medicine into practice.
Clinical Use Remains Distant, but Progress Offers Hope
The technology is still at an early experimental stage and remains far from use in human treatment. Dr. Flannigan acknowledges that further funding, more complex biosafety studies, and ethical and regulatory review will be needed.
“But we have a clear goal: for this technology eventually to help patients for whom medicine currently has no options.”
Along the way, the team will continue uncovering the molecular mechanisms behind male infertility and opening new avenues for research.
Story source:
Collected online